189 related articles for article (PubMed ID: 9678104)
1. The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery.
Van Kets H; Van der Pas H; Thiery M; Wildemeersch D; Vrijens M; Van Trappen Y; Temmerman M; DePypere H; Delbarge W; Dhont M; Defoort P; Schacht EH; Bàtàr I; Barri P; Martinez F; Iglesias Cortit LH; Creatsas G; Shangchun W; Xiaoming C; Zuan-chong F; Yu-ming W; Andrade A; Reinprayoon D; Pizarro E
Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):1-13. PubMed ID: 9678104
[TBL] [Abstract][Full Text] [Related]
2. [Intrauterine copper contraceptive implants].
Van Kets H; Thiery M; Wildemeersch D; Delbarge W; Vrijens M; Van der Pas H; Depypere H; Parewijck W; Temmerman M; Van Trappen Y; Van den Ostende G
Contracept Fertil Sex; 1996 Dec; 24(12):908-11. PubMed ID: 9026279
[TBL] [Abstract][Full Text] [Related]
3. The frameless GyneFix intrauterine implant: a major improvement in efficacy, expulsion and tolerance.
van Kets H; Vrijens M; Van Trappen Y; Delbarge W; van der Pas H; Temmerman M; Depypere H; Batar I; Barri P; Martinez F
Adv Contracept; 1995 Jun; 11(2):131-42. PubMed ID: 7491854
[TBL] [Abstract][Full Text] [Related]
4. Current status of frameless anchored IUD for immediate intracesarean insertion.
Wildemeersch D; Goldstuck ND; Hasskamp T
Dev Period Med; 2016; 20(1):7-15. PubMed ID: 27416620
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
6. GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraception.
Wildemeersch D; Batár I; Webb A; Gbolade BA; Delbarge W; Temmerman M; Dhont M; Guillebaud J
Br J Fam Plann; 1999 Jan; 24(4):149-59. PubMed ID: 10023101
[TBL] [Abstract][Full Text] [Related]
7. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
8. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
Wu S; Hu J; Wildemeersch D
Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
[TBL] [Abstract][Full Text] [Related]
9. Intrauterine contraception.
Reinprayoon D
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):527-30. PubMed ID: 1324024
[TBL] [Abstract][Full Text] [Related]
10. Postpartum IUDS: keys for success.
O'Hanley K; Huber DH
Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
[TBL] [Abstract][Full Text] [Related]
11. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
12. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
Malhotra N; Chaudhury RR
Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
[TBL] [Abstract][Full Text] [Related]
13. Preventing abortion and repeat abortion with the Gynefix intrauterine implant system--preliminary results.
Batar I; Wildemeersch D; Vrijens M; Delbarge W; Temmerman M; Gbolade BA
Adv Contracept; 1998 Jun; 14(2):91-6. PubMed ID: 9820927
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine device developments.
Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
[TBL] [Abstract][Full Text] [Related]
15. Five years private practice experience of nulliparous women using copper IUD's.
Smith RP; Goresky DM; Etchell DM
Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with a novel anchored, frameless copper-releasing contraceptive device for intra-caesarean insertion.
Eser A; Unal C; Albayrak B; Wildemeersch D
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):255-259. PubMed ID: 30273057
[TBL] [Abstract][Full Text] [Related]
17. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine devices: present and future.
Guillebaud J
Int J Gynaecol Obstet; 1980; 18(5):325-32. PubMed ID: 6110576
[TBL] [Abstract][Full Text] [Related]
19. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
Lavin P; Waszak C; Bravo C
Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
[TBL] [Abstract][Full Text] [Related]
20. A clinical trial of the Delta-T intrauterine device: immediate postpartum insertion.
Brenner PF
Contraception; 1983 Aug; 28(2):135-47. PubMed ID: 6357630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
